Every product that makes a shelf life or expiration date claim needs stability data to support it. Stability testing measures how a product's quality attributes change over time under defined environmental conditions, providing the scientific basis for establishing storage conditions and expiration dating. The International Council for Harmonisation (ICH) has published guidelines that define the framework for stability testing — and understanding these guidelines is essential for anyone developing pharmaceuticals, supplements, or related products.
What Is ICH Q1A?
ICH Q1A(R2), titled "Stability Testing of New Drug Substances and Drug Products," is the foundational guideline for pharmaceutical stability testing. While it was written primarily for pharmaceutical products, its principles are widely applied to dietary supplements, cosmetics, and other regulated products. The guideline defines study designs, storage conditions, testing intervals, and data evaluation approaches.
The core principle of ICH Q1A is straightforward: subject your product to controlled environmental conditions, test it at defined intervals, and use the resulting data to establish how long the product maintains its quality specifications.
Study Types and Storage Conditions
ICH Q1A defines three primary study types, each serving a different purpose:
Long-Term Studies — These are conducted at the recommended storage condition for the product and provide the primary data for establishing shelf life. For products stored at room temperature, the standard condition is 25°C ± 2°C / 60% RH ± 5% RH. Testing is performed at 0, 3, 6, 9, 12, 18, 24, and 36 months (and beyond if needed).
Intermediate Studies — Conducted at 30°C ± 2°C / 65% RH ± 5% RH, these studies provide additional data when significant change is observed during accelerated testing. Testing intervals are 0, 6, 9, and 12 months.
Accelerated Studies — Conducted at 40°C ± 2°C / 75% RH ± 5% RH, these studies are designed to predict long-term stability by exposing the product to stress conditions. If no significant change occurs over 6 months of accelerated storage, the data can support a tentative shelf life of up to 24 months while long-term data is being collected. Testing is performed at 0, 3, and 6 months.
For products requiring refrigerated storage, different conditions apply: long-term at 5°C ± 3°C, and accelerated at 25°C ± 2°C / 60% RH ± 5% RH.
What to Test
The specific tests included in a stability protocol depend on the product type, but generally cover the quality attributes most likely to change over time:
Physical attributes — Appearance, color, odor, pH, viscosity, dissolution rate, and other organoleptic or physical properties.
Chemical attributes — Assay (potency), degradation products, related substances, and any other chemical specifications. HPLC is the most common technique for monitoring chemical stability.
Microbiological attributes — Total aerobic microbial count, yeast and mold count, and absence of specified pathogens. Particularly important for products containing water or those stored in multi-dose containers.
Container-closure integrity — For products in sealed containers, verifying that the packaging continues to protect the product from moisture, oxygen, and microbial ingress.
Designing a Stability Protocol
A well-designed stability protocol should specify:
1. Batch selection — ICH Q1A recommends testing a minimum of three batches. For new product submissions, at least two of these should be pilot-scale or production-scale batches manufactured using the intended commercial process.
2. Container-closure system — Stability samples must be stored in the same packaging system intended for commercial distribution. Testing product in a different container can yield misleading results.
3. Testing intervals — Follow the ICH-recommended intervals for each study type. For long-term studies, testing frequency can be reduced after 12 months (e.g., every 6 months through 24 months, then annually).
4. Acceptance criteria — Define numerical limits for each test parameter that constitute "significant change." ICH Q1A defines significant change for drug products as a 5% change in assay from initial value, or failure to meet specifications for degradation products, appearance, or dissolution.
5. Statistical analysis — ICH Q1E provides guidance on using regression analysis to estimate shelf life from stability data, including approaches for pooling data across batches and strengths.
Accelerated Studies: What They Can and Cannot Tell You
Accelerated stability studies are valuable for early-stage development because they provide rapid information about potential degradation pathways and can support tentative shelf life claims. However, they have important limitations:
They predict, not prove. Accelerated data uses the Arrhenius equation to extrapolate from high-temperature behavior to room-temperature shelf life. This assumes that the degradation mechanism does not change with temperature — an assumption that does not always hold true.
They cannot replace long-term data. Regulatory agencies require long-term stability data for final shelf life approval. Accelerated studies provide interim support while long-term studies are ongoing.
They may miss slow-developing changes. Some degradation pathways — such as oxidation, polymerization, or physical changes like crystallization — may not be adequately predicted by short-term accelerated studies.
How ILS Laboratories Supports Stability Programs
ILS Laboratories provides comprehensive stability testing services aligned with ICH guidelines. We work with clients to design stability protocols appropriate for their product type and regulatory pathway, then execute the testing program with consistent methodology across all time points.
Our stability testing capabilities include potency and purity by HPLC, degradation product profiling, microbiological testing, pH measurement, dissolution testing, and physical appearance evaluation. All testing is performed under our ISO 17025 quality system, ensuring that your stability data is defensible and suitable for regulatory submissions.
Whether you need a full ICH-compliant stability program for a new product submission or accelerated studies to support preliminary shelf life claims, our team can help you design and execute a testing strategy that meets your development timeline and regulatory requirements.